Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record.

Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide

Li, Ping, Chappell, Mark C., Ferrario, Carlos M., Brosnihan, K. Bridget·1997·Hypertension

Abstract

Recent studies have shown that angiotensin-(1–7) [Ang-(1–7)] interacts with kinins and augments bradykinin (BK)-induced vasodilator responses by an unknown mechanism. In this study, we evaluated whether the potentiation of the BK-induced vasodilation by Ang-(1–7) may be attributable to inhibition of BK metabolism, release of nitric oxide, or both. Isometric tension was measured in intact canine coronary artery rings suspended in organ chambers.125 I-[Tyr 0]-BK metabolism was determined in vascular rings by assessing the degradation of the peptide by high-performance liquid chromatography. Ang-(1–7) augmented the vasodilation induced by BK in a concentration-dependent manner in rings preconstricted with the thromboxane analog U46619. The EC 50 of BK (2.45±0.51 nmol/L versus 0.37±0.08 nmol/L) was shifted leftward by 6.6-fold in the presence of 2 μmol/L concentration of Ang-(1–7). The response was specific for BK, since Ang-(1–7) did not augment the vasodilation induced by either acetylcholine (0.05 μmol/L) or sodium nitroprusside (0.1 μmol/L). Moreover, neither angiotensin I nor angiotensin II (Ang II) duplicated the augmented BK response of Ang-(1–7). Pretreatment of vascular rings with the nitric oxide synthase inhibitor,Nω-nitro-l-arginine (L-NA; 100 μmol/L) completely abolished the effects of Ang-(1–7) on BK-induced vasodilation whereas pretreatment with indomethacin (10 μmol/L) was without effect. The potent specific BK B 2 receptor antagonist, Hoe 140, nearly abolished the BK and the Ang-(1–7) potentiated responses at 2 μmol/L, whereas at a lower concentration (20 nmol/L) Hoe 140 shifted the response curve to the right for both Ang-(1–7) and vehicle; however, the augmented response to Ang-(1–7) persisted. Preincubation of vascular rings with 20 μmol/L of the AT 1(CV11974), AT 2(PD123319), or nonselective (Sar 1 Thr 8-Ang II) receptor antagonists had no significant effect on the Ang-(1–7)-enhanced vasodilator response to BK. Lisinopril (2 μmol/L) significantly enhanced the BK-induced vasodilator response while at the same time it abolished the synergistic action of Ang-(1–7) on BK. In addition, pretreatment with 2 μmol/L Ang-(1–7) significantly inhibited the degradation of 125 I-[Tyr 0]-BK and the appearance of the BK-(1–7) and BK-(1–5) metabolites in coronary vascular rings. Ang-(1–7) inhibited purified canine angiotensin converting enzyme activity with an IC 50 of 0.65 μmol/L. In conclusion, Ang-(1–7) acts as a local synergistic modulator of kinin-induced vasodilation by inhibiting angiotensin converting enzyme and releasing nitric oxide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.29.1.394

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 246

Metadata

Authors
Li, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B.
Venue
Hypertension
Published
1997-01
Volume
29
Issue
1
Pages
394-398
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2103115053
Cited by
246
References
0
FWCI
9.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide. https://app.cochat.ai/papers/10.1161/01.hyp.29.1.394
The paper
Li, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997). Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide. Hypertension. https://doi.org/10.1161/01.hyp.29.1.394

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.